Follow-The-Filings

Security · featured owners

XERS Xeris Biopharma Holdings Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.1%
  • $827K

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (Palo Alto Investors) · not free-float ownership

  1. Palo Alto Investors 0.11%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Palo Alto Investors 2026 Q2 0.11% Hold 104,410 $827K history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $163.91M $203.07M $291.84M
Net income -$62.26M -$54.84M $554,000
Net margin * -38.0% -27.0% 0.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $156.26M $167.66M $240.31M
Total non-current assets * $166.34M $155.4M $143.21M
Total assets $322.6M $323.06M $383.53M
Total current liabilities $95.19M $100.44M $109.57M
Total non-current liabilities * $234.19M $252.23M $260.26M
Total equity -$6.78M -$29.62M $13.69M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$47.02M -$36.98M $28.63M
Cash from investing -$6M $4.88M -$696,000
Cash from financing -$1.61M $36.17M $11.39M
Net change in cash -$54.64M $4.07M $39.32M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders